Dolphin Pharmatech

Pharmaceutical products for hair, skin, and disease treatments in India.

About Dolphin Pharmatech

Dolphin Pharmatech is a Consumer company. Pharmaceutical products for hair, skin, and disease treatments in India. It operates in the Consumer and Healthcare sectors. Its Indian entity Dolphin Pharmatech Private Limited reported revenue of β‚Ή2.04 Cr. Dolphin Pharmatech offers products and services including Hair Care Products and Skin Care Products. Its focus areas include Pharmaceuticals, Medical Products, Hair and Skin Formulations and Disease Treatments.

Company details

Healthcare products are offered by Dolphin Pharmatech, encompassing a wide range for hair care, skin care, and treatments for fungal and allergic conditions, all developed with highly purified agents and vegetable-sourced formulations. These products are made available exclusively in India, emphasizing integrity, ethics, and commitment to quality standards without compromise. Services are directed towards all segments of society, focusing on preventive care and overall health maintenance, as standards are maintained through careful formulation processes.

Key Metrics
  • Indian entity revenue
    ₹2.04 Cr

    FY 2025 · -14% YoY

  • Indian entity net profit
    ₹1.9 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹5.2 Lakh

    FY 2025 · 3% margin

Products & Services of Dolphin Pharmatech

Dolphin Pharmatech offers a comprehensive portfolio of products and services, including Hair Care Products and Skin Care Products.

Hair Care Products
Healthcare Products

Hair care products are provided for preventive care and maintenance of healthy hair

Skin Care Products
Healthcare Products

Skin care products are supplied for treatments related to pigmentation and other skin conditions

Board of directors of Dolphin Pharmatech Private Limited (Dolphin Pharmatech)

Dolphin Pharmatech Private Limited is the primary company behind Dolphin Pharmatech. The board of Dolphin Pharmatech Private Limited currently have 4 directors; the longest-serving is Vishal Anilbhai Shah, appointed in 2018.

DirectorDesignationAppointedTenureEntity
Vishal Anilbhai Shah
DIN 07842346
Director07 Mar 20188 yrs 8 moDolphin Pharmatech Private Limited
Nishantkumar Kanaiyalal Patel
DIN 07842328
Director07 Mar 20188 yrs 8 moDolphin Pharmatech Private Limited
Poojaben Nishantkumar Patel
DIN 07842331
Director07 Mar 20188 yrs 8 moDolphin Pharmatech Private Limited
Namrata Vishal Shah
DIN 07842335
Director07 Mar 20188 yrs 8 moDolphin Pharmatech Private Limited

Financials of Dolphin Pharmatech

Figures of Dolphin Pharmatech Private Limited, the primary company behind Dolphin Pharmatech, for FY 2025. Revenue was ₹2.04 Cr (-14% year on year). Net profit was ₹1.9 Lakh (1% margin). EBITDA was ₹5.2 Lakh (3% margin). Revenue has grown at a compounded annual rate of +11% over three years and +13% over five years.

  • ₹2.04 CrRevenue · FY 2025 · -14% YoY
  • ₹1.9 LakhNet profit · 1% margin
  • ₹5.2 LakhEBITDA · 3% margin
  • ₹1 LakhPaid-up capital
  • +11%Revenue CAGR, 3 years
  • +13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Dolphin Pharmatech Private Limited are on its company page.

Premium access

Detailed financial statements for Dolphin Pharmatech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dolphin Pharmatech

The primary company behind Dolphin Pharmatech, Dolphin Pharmatech Private Limited, reported revenue of β‚Ή2.04 Cr for FY 2025, down 14% year on year.

Healthcare products are offered by Dolphin Pharmatech, encompassing a wide range for hair care, skin care, and treatments for fungal and allergic conditions, all developed with highly purified agents and vegetable-sourced formulations. These products are made available exclusively in India, emphasizing integrity, ethics, and commitment to quality standards without compromise. Services are directed towards all segments of society, focusing on preventive care and overall health maintenance, as standards are maintained through careful formulation processes.

Dolphin Pharmatech offers Hair Care Products and Skin Care Products.

Dolphin Pharmatech operates through Dolphin Pharmatech Private Limited.

The legal entities of Dolphin Pharmatech currently have 4 directors, including Vishal Anilbhai Shah, Nishantkumar Kanaiyalal Patel, Poojaben Nishantkumar Patel and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available